Change of Name

Recorded: 2003-06-27 Received: 2003-06-27 Pages: 5

Assignor

GENZYME TRANSGENICS CORPORATION

Executed: 2002-05-22

Assignee

GTC BIOTHERAPEUTICS, INC.

175 CROSSING BLVD., SUITE 410, FRAMINGHAM, MA, 01702, UNITED STATES

Covered Properties (15)

Transgenic and cloned mammals

Application: 10/423,792 →

Methods of tangential flow filtration and an apparatus therefore

Application: 60/449,786 →

Transgenically produced non-secreted proteins

Application: 10/358,037 →

Method and system for fusion and activation following nuclear transfer in reconstructed embryos

Application: 10/338,546 →

Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds

Application: 60/411,419 →

Method for the rapid selection of homozygous primary cell lines for the production of transgenic animals by somatic cell nuclear transfer

Application: 60/400,344 →

Treatments Using Transgenic Goat Produced Antithrombin Iii

Application: 10/188,658 →

Purification of human serum albumin

Application: 10/172,159 →

Methods and vectors for improving nucleic acid expression

Application: 10/137,618 →

Erythropoietin Analog-Human Serum Albumin Fusion

Application: 10/081,400 →

Non-Human Transgenic Mammal Comprising a Modified Msp-1 Nucleic Acid

Application: 10/082,018 →

Composition and methods for prevention of photoaging

Application: 09/913,697 →

Cryopreservation of sperm

Application: 09/927,824 →

Transgenically produced platelet derived growth factor

Application: 09/884,586 →

Transgenically produced decorin

Application: 09/849,657 →